US Bancorp’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.55K | Buy |
1,887
+828
| +78% | +$2K | ﹤0.01% | 3663 |
|
|
2025
Q1 | $2.34K | Sell |
1,059
-2,757
| -72% | -$6.09K | ﹤0.01% | 3831 |
|
|
2024
Q4 | $20.8K | Buy |
3,816
+97
| +3% | +$529 | ﹤0.01% | 3132 |
|
|
2024
Q3 | $30.9K | Buy |
3,719
+264
| +8% | +$2.19K | ﹤0.01% | 2949 |
|
|
2024
Q2 | $24.7K | Sell |
3,455
-88
| -2% | -$630 | ﹤0.01% | 2970 |
|
|
2024
Q1 | $30.7K | Sell |
3,543
-410
| -10% | -$3.56K | ﹤0.01% | 2919 |
|
|
2023
Q4 | $25.9K | Buy |
3,953
+681
| +21% | +$4.46K | ﹤0.01% | 2937 |
|
|
2023
Q3 | $32.7K | Buy |
3,272
+2,360
| +259% | +$23.6K | ﹤0.01% | 2640 |
|
|
2023
Q2 | $11.3K | Sell |
912
-5,097
| -85% | -$63.3K | ﹤0.01% | 3187 |
|
|
2023
Q1 | $84.2K | Buy |
6,009
+2,472
| +70% | +$34.6K | ﹤0.01% | 2271 |
|
|
2022
Q4 | $50.6K | Sell |
3,537
-17,865
| -83% | -$256K | ﹤0.01% | 2514 |
|
|
2022
Q3 | $547K | Sell |
21,402
-31,254
| -59% | -$799K | ﹤0.01% | 1346 |
|
|
2022
Q2 | $1.5M | Buy |
52,656
+52,555
| +52,035% | +$1.49M | ﹤0.01% | 928 |
|
|
2022
Q1 | $4K | Sell |
101
-56
| -36% | -$2.22K | ﹤0.01% | 3652 |
|
|
2021
Q4 | $6K | Sell |
157
-417
| -73% | -$15.9K | ﹤0.01% | 3564 |
|
|
2021
Q3 | $28K | Sell |
574
-4
| -0.7% | -$195 | ﹤0.01% | 2934 |
|
|
2021
Q2 | $24K | Buy |
578
+534
| +1,214% | +$22.2K | ﹤0.01% | 3030 |
|
|
2021
Q1 | $1K | Hold |
44
| – | – | ﹤0.01% | 3765 |
|
|
2020
Q4 | $1K | Buy |
+44
| New | +$1K | ﹤0.01% | 3641 |
|